That’s good to hear tsuba, not only is it evidence of continuing Evolis products, potential profits from that segment but also presumably future Midkine royalties.
in turn of course the expected sp increase as the company renaissance progresses.
Ann: Appendix 4E and Preliminary Final Report, page-9
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.691M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 636992 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 146491 | 1 |
View Market Depth
| Last trade - 10.00am 26/06/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable